Global Coronary Stents – Industry Trends and Forecast to 2024

Global coronary stents market is expected to reach USD 6.4 billion by 2024 from USD 5.3 billion in 2016, at a CAGR of 2.4% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request for Sample Report @ http://databridgemarketresearch.com/request-a-sample/?chalet=coronary-stents-market-trends-forecast-2024/

The global coronary stents market is segmented on the basis of product type, portability, application, end-user, and geography.

Browse Full Report with Details TOC @ http://databridgemarketresearch.com/reports/coronary-stents-market-trends-forecast-2024/

On the basis of type, the global coronary stents market is segmented into dual therapy stent, bioresorbable vascular scaffold (BVS), drug eluting stent (DES), bio-engineered stent, bare metal stent.

On the basis of application, the coronary stents market is segmented into coronary artery disease, and peripheral artery disease.

The market is also segmented on the basis of end-user into hospitals, and cardiac centres.

Based on geography, the market is segmented into five geographical regions:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa
  • Rest of the World.

The geographical regions are further segmented into major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

The Global Coronary Stent Market Report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.

Some of the major players operating in this market are

  • Abbott Vascular
  • SciTech
  • Boston Scientific Corporation
  • Minvasys
  • Medinol Ltd
  • iVascular SLU
  • Elixir Medical Corporation
  • Inspire MD
  • Stentys SA
  • Hexacath
  • Medtronic
  • Andramed GmbH
  • Cordis Corporation
  • Orbusneich
  • Eurocor GmbH
  • Comed B.V.
  • Endocor GmbH
  • MicroPort Scientific Corporation
  • Amaranth Medical, Inc.
  • Terumo Corporation
  • Degania Silicone Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • InSitu Technologies Inc.
  • Alvimedica
  • Biotronik SE & Co. KG
  • AMG International GmbH
  • Arthesys
  • Lepu Medical
  • Translumina GmbH
  • Accura
  • Svelte Medical
  • Braun Melsungen AG
  • Eucatech AG

 

Inquiry before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?chalet=coronary-stents-market-trends-forecast-2024/

Table Of Content:

  1. INTRODUCTION

1.1. OVERVIEW OF THE GLOBAL CORONARY STENTS MARKET

1.2. MARKET SEGMENTATION & COVERAGE

1.2.1. CURRENCY AND PRICING

1.2.2. LIMITATION

1.2.3. STAKEHOLDERS

  1. RESEARCH METHODOLOGY

2.1. KEY TAKEAWAYS

2.2. ARRIVING AT THE GLOBAL CORONARY STENTS MARKET SIZE

2.2.1. MARKET CRACKDOWN APPROACH

2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

2.2.3. DATA TRIANGULATION

2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES

2.2.6. PORTER’S FIVE FORCES MATRIX

2.3. GLOBAL CORONARY STENTS MARKET: RESEARCH SNAPSHOT

2.4. ASSUMPTIONS

  1. MARKET LANDSCAPE SUMMARY
  2. PREMIUM INSIGHTS

4.1. OVERVIEW

4.2. GLOBAL CORONARY STENTS MARKET: KEY PRIMARY INSIGHTS

4.3. MARKET OVERVIEW

4.3.1. DRIVERS

4.3.2. RESTRAINTS

4.3.3. OPPOTUNITIES

4.3.4. THREATS

4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

  1. GLOBAL CORONARY STENTS MARKET, BY TYPE

5.1. OVERVIEW

5.2. DUAL THERAPY STENT

5.3. BIORESORBABLE VASCULAR SCAFFOLD

5.4. DRUG ELUTING STENT (DES)

5.4.1. PACLITAXEL

5.4.2. IMUS-BASED DRUGS

5.5. BIO-ENGINEERED STENT

5.6. BARE METAL STENT

  1. GLOBAL CORONARY STENTS MARKET, BY ABSORPTION RATE

6.1. SLOW-ABSORPTION DES

6.2. FAST-ABSORPTION (DES)

  1. GLOBAL CORONARY STENTS MARKET, BY MATERIAL

7.1. OVERVIEW

7.2. STAINLESS STEEL

7.3. COBALT ALLOY METAL

7.4. GOLD

7.5. TANTALUM

7.6. NITINOL

7.7. POLYMERS

  1. GLOBAL CORONARY STENTS MARKET, BY RATE

8.1. OVERVIEW

8.2. SLOW-ABSORPTION STENTS

8.3. FAST-ABSORPTION STENTS

  1. GLOBAL CORONARY STENTS MARKET, BY APPLICATION

9.1. CORONARY ARTERY DISEASE

9.2. PERIPHERAL ARTERY DISEASE

  1. GLOBAL CORONARY STENTS MARKET, BY END USER

10.1. HOSPITALS

10.2. CARDIAC CENTERS

10.3. OTHERS

  1. GLOBAL CORONARY STENTS MARKET, BY GEOGRAPHY

11.1. COUNTRYWISE CORONARY STENTS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

11.1.1. NORTH AMERICA

11.1.1.1. U.S.

11.1.1.2. CANADA

11.1.1.3. MEXICO

11.1.2. EUROPE

11.1.2.1. GERMANY

11.1.2.2. FRANCE

11.1.2.3. U.K.

11.1.2.4. ITALY

11.1.2.5. SPAIN

11.1.2.6. RUSSIA

11.1.2.7. TURKEY

11.1.2.8. BELGIUM

11.1.2.9. NETHERLANDS

11.1.2.10. SWITZERLAND

11.1.2.11. REST OF EUROPE

11.1.3. ASIA-PACIFIC (APAC)

11.1.3.1. JAPAN

11.1.3.2. CHINA

11.1.3.3. SOUTH KOREA

11.1.3.4. INDIA

11.1.3.5. AUSTRALIA

11.1.3.6. SINGAPORE

11.1.3.7. THAILAND

11.1.3.8. MALAYSIA

11.1.3.9. INDONESIA

11.1.3.10. PHILIPPINES

11.1.3.11. REST OF APAC

11.1.4. SOUTH AMERICA

11.1.4.1. BRAZIL

11.1.4.2. REST OF SOUTH AMERICA

11.1.5. MIDDLE EAST AND AFRICA

11.1.5.1. SOUTH AFRICA

11.1.5.2. REST OF MIDDLE EAST AND AFRICA

11.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

  1. GLOBAL CORONARY STENTS MARKET: COMPETITIVE LANDSCAPE

12.1. GLOBAL CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS

12.2. U.S. CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS

12.3. EUROPE CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS

12.4. APAC CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS

12.5. SOUTH AMERICA CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS

12.6. MIDDLE EAST AND AFRICA CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS

12.7. MERGERS & ACQUISITIONS

12.8. NEW PRODUCT DEVELOPMENT & APPROVALS

12.9. EXPANSIONS

12.10. REGULATORY CHANGES

12.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

  1. GLOBAL CORONARY STENTS MARKET, COMPANY PROFILES

13.1. ABBOTT VASCULAR

13.1.1. OVERVIEW

13.1.2. SWOT ANALYSIS

13.1.3. PRODUCT PORTFOLIO

13.1.4. REVENUE ANALYSIS

13.1.5. ANALYSTS VIEW

13.2. SCITECH

13.2.1. OVERVIEW

13.2.2. SWOT ANALYSIS

13.2.3. PRODUCT PORTFOLIO

13.2.4. REVENUE ANALYSIS

13.2.5. ANALYSTS VIEW

13.3. BOSTON SCIENTIFIC CORPORATION

13.3.1. OVERVIEW

13.3.2. SWOT ANALYSIS

13.3.3. PRODUCT PORTFOLIO

13.3.4. REVENUE ANALYSIS

13.3.5. ANALYST VIEW

13.4. MEDINOL LTD

13.4.1. OVERVIEW

13.4.2. SWOT ANALYSIS

13.4.3. PRODUCT PORTFOLIO

13.4.4. REVENUE ANALYSIS

13.4.5. ANALYSTS VIEW

13.5. IVASCULAR SLU

13.5.1. OVERVIEW

13.5.2. SWOT ANALYSIS

13.5.3. PRODUCT PORTFOLIO

13.5.4. REVENUE ANALYSIS

13.5.5. ANALYSTS VIEW

13.6. STENTYS SA

13.6.1. OVERVIEW

13.6.2. SWOT ANALYSIS

13.6.3. PRODUCT PORTFOLIO

13.6.4. REVENUE ANALYSIS

13.6.5. ANALYSTS VIEW

13.7. ELIXIR MEDICAL CORPORATION

13.7.1. OVERVIEW

13.7.2. SWOT ANALYSIS

13.7.3. PRODUCT PORTFOLIO

13.7.4. REVENUE ANALYSIS

13.7.5. ANALYSTS VIEW

13.8. INSPIRE MD

13.8.1. OVERVIEW

13.8.2. SWOT ANALYSIS

13.8.3. PRODUCT PORTFOLIO

13.8.4. REVENUE ANALYSIS

13.8.5. ANALYSTS VIEW

13.9. HEXACATH

13.9.1. OVERVIEW

13.9.2. SWOT ANALYSIS

13.9.3. PRODUCT PORTFOLIO

13.9.4. REVENUE ANALYSIS

13.9.5. ANALYSTS VIEW

13.10. MEDTRONIC

13.10.1. OVERVIEW

13.10.2. SWOT ANALYSIS

13.10.3. PRODUCT PORTFOLIO

13.10.4. REVENUE ANALYSIS

13.10.5. ANALYSTS VIEW

13.11. ORBUSNEICH

13.11.1. OVERVIEW

13.11.2. SWOT ANALYSIS

13.11.3   PRODUCT PORTFOLIO

13.11.4   REVENUE ANALYSIS

13.11.5   ANALYSTS VIEW

13.12. ANDRAMED GMBH

13.12.1. OVERVIEW

13.12.2. SWOT ANALYSIS

13.12.3. PRODUCT PORTFOLIO

13.12.4. REVENUE ANALYSIS

13.12.5. ANALYSTS VIEW

13.13. CORDIS CORPORATION

13.13.1. OVERVIEW

13.13.2. SWOT ANALYSIS

13.13.3. PRODUCT PORTFOLIO

13.13.4. REVENUE ANALYSIS

13.13.5. ANALYSTS VIEW

13.14. ENDOCOR GMBH

13.14.1. OVERVIEW

13.14.2. SWOT ANALYSIS

13.14.3. PRODUCT PORTFOLIO

13.14.4. REVENUE ANALYSIS

13.14.5. ANALYSTS VIEW

13.15. EUROCOR GMBH

13.15.1. OVERVIEW

13.15.2. SWOT ANALYSIS

13.15.3. PRODUCT PORTFOLIO

13.15.4. REVENUE ANALYSIS

13.15.5. ANALYSTS VIEW

13.16. COOK MEDICAL.

13.16.1. OVERVIEW

13.16.2. SWOT ANALYSIS

13.16.3. PRODUCT PORTFOLIO

13.16.4. REVENUE ANALYSIS

13.16.5. ANALYSTS VIEW

13.17. MICROPORT SCIENTIFIC CORPORATION

13.17.1. OVERVIEW

13.17.2. SWOT ANALYSIS

13.17.3. PRODUCT PORTFOLIO

13.17.4. REVENUE ANALYSIS

13.17.5. ANALYSTS VIEW

13.18. DEGANIA SILICONE LTD.

13.18.1. OVERVIEW

13.18.2. SWOT ANALYSIS

13.18.3. PRODUCT PORTFOLIO

13.18.4. REVENUE ANALYSIS

13.18.5. ANALYSTS VIEW

13.19. TERUMO CORPORATION

13.19.1. OVERVIEW

13.19.2. SWOT ANALYSIS

13.19.3. PRODUCT PORTFOLIO

13.19.4. REVENUE ANALYSIS

13.19.5. ANALYSTS VIEW

13.20. MERIL LIFE SCIENCES PVT. LTD.

13.20.1. OVERVIEW

13.20.2. SWOT ANALYSIS

13.20.3. PRODUCT PORTFOLIO

13.20.4. REVENUE ANALYSIS

13.20.5. ANALYSTS VIEW

13.21. ALVIMEDICA

13.21.1. OVERVIEW

13.21.2. SWOT ANALYSIS

13.21.3. PRODUCT PORTFOLIO

13.21.4. REVENUE ANALYSIS

13.21.5. ANALYSTS VIEW

13.22. ELIXIR MEDICAL CORPORATION

13.22.1. OVERVIEW

13.22.2. SWOT ANALYSIS

13.22.3. PRODUCT PORTFOLIO

13.22.4. REVENUE ANALYSIS

13.22.5. ANALYSTS VIEW

13.23. INSITU TECHNOLOGIES INC.

13.23.1. OVERVIEW

13.23.2. SWOT ANALYSIS

13.23.3. PRODUCT PORTFOLIO

13.23.4. REVENUE ANALYSIS

13.23.5. ANALYSTS VIEW

13.24. BIOTRONIK SE & CO. KG

13.24.1. OVERVIEW

13.24.2. SWOT ANALYSIS

13.24.3. PRODUCT PORTFOLIO

13.24.4. REVENUE ANALYSIS

13.24.5. ANALYSTS VIEW

13.25. AMG INTERNATIONAL GMBH

13.25.1. OVERVIEW

13.25.2. SWOT ANALYSIS

13.25.3. PRODUCT PORTFOLIO

13.25.4. REVENUE ANALYSIS

13.25.5. ANALYSTS VIEW

13.26. ARTHESYS

13.26.1. OVERVIEW

13.26.2. SWOT ANALYSIS

13.26.3. PRODUCT PORTFOLIO

13.26.4. REVENUE ANALYSIS

13.26.5. ANALYSTS VIEW

13.27. TRANSLUMINA GMBH

13.27.1. OVERVIEW

13.27.2. SWOT ANALYSIS

13.27.3. PRODUCT PORTFOLIO

13.27.4. REVENUE ANALYSIS

13.27.5. ANALYSTS VIEW

13.28. LEPU MEDICAL

13.28.1. OVERVIEW

13.28.2. SWOT ANALYSIS

13.28.3. PRODUCT PORTFOLIO

13.28.4. REVENUE ANALYSIS

13.28.5. ANALYSTS VIEW

13.29. ACCURA

13.29.1. OVERVIEW

13.29.2. SWOT ANALYSIS

13.29.3. PRODUCT PORTFOLIO

13.29.4. REVENUE ANALYSIS

13.29.5. ANALYSTS VIEW

13.30. CELONOVA BIOSCIENCES, INC.

13.30.1. OVERVIEW

13.30.2. SWOT ANALYSIS

13.30.3. PRODUCT PORTFOLIO

13.30.4. REVENUE ANALYSIS

13.30.5. ANALYSTS VIEW

13.31. MINVASYS

13.31.1. OVERVIEW

13.31.2. SWOT ANALYSIS

13.31.3. PRODUCT PORTFOLIO

13.31.4. REVENUE ANALYSIS

13.31.5. ANALYSTS VIEW

13.32. SVELTE MEDICAL

13.32.1. OVERVIEW

13.32.2. SWOT ANALYSIS

13.32.3. PRODUCT PORTFOLIO

13.32.4. REVENUE ANALYSIS

13.32.5. ANALYSTS VIEW

13.33. B. BRAUN MELSUNGEN AG

13.33.1. OVERVIEW

13.33.2. SWOT ANALYSIS

13.33.3. PRODUCT PORTFOLIO

13.33.4. REVENUE ANALYSIS

13.33.5. ANALYSTS VIEW

13.34. EUCATECH AG

13.34.1. OVERVIEW

13.34.2. SWOT ANALYSIS

13.34.3. PRODUCT PORTFOLIO

13.34.4. REVENUE ANALYSIS

13.34.5. ANALYSTS VIEW

  1. APPENDIX
  2. ABOUT DATA BRIDGE MARKET RESEARCH

Related Report

Global Vital Signs Monitoring Market – Industry Trends and Forecast to 2024

Global Vital Signs Monitoring Market, By Product (Blood Pressure Monitoring (Aneroid BP Monitors, Automated BP Monitors, Ambulatory BP Monitors, BP Device Accessories), Pulse Oximeter (Tabletop/Bedside Pulse Oximeter, Fingertip, Handheld, Wrist Worn, Pediatric Pulse Oximeter, Pulse Oximeter Accessories), Temperature Monitoring Devices (Mercury-Filled Thermometers, Digital Thermometers, Infrared Thermometers, Temperature Strips, Temperature Monitoring Devices Accessories)), By Type (Standalone, Portable), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Online Websites, Others), By End Users (Hospitals  & Clinics, Ambulatory Surgery Centers, Home Healthcare, Diagnostic Center, Others), By Geography (North America, Europe, Asia Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

http://databridgemarketresearch.com/reports/global-vital-signs-monitoring-devices-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Ankit Singh

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor: investors@databridgemarketresearch.com

Visit Blog http://databridgemarketresearch.com/blog/

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

%d bloggers like this: